Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shanmiao Gou

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling

Scientific Reports

Multidisciplinary

English

Related publications

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research

Cancer Research

English

CD133 Antisense Suppresses Cancer Cell Growth and Increases Sensitivity to Cisplatin in Vitro

Experimental and Therapeutic Medicine

Cancer Research

English

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer

Cancer Research

English

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

English

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters

Cancer Research

English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

Multidisciplinary

English

Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway

Asian Pacific Journal of Cancer Prevention

English

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current Molecular Medicine

Molecular Medicine

Molecular Biology

English

Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway

Cancer Management and Research

English